{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:45:25Z","timestamp":1794440725419,"version":"4.9.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG044546"],"award-info":[{"award-number":["R01AG044546"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-025-00872-8","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T06:15:15Z","timestamp":1747721715000},"page":"1114-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-2848","authenticated-orcid":false,"given":"Gyujin","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6631","authenticated-orcid":false,"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-7593","authenticated-orcid":false,"given":"Hamilton Se-Hwee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Moran-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9304-5421","authenticated-orcid":false,"given":"Federica","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Gonz\u00e1lez Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-5893","authenticated-orcid":false,"given":"Raquel","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3201-6031","authenticated-orcid":false,"given":"Soomin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigyasha","family":"Timsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-9553","authenticated-orcid":false,"given":"Daniel","family":"Western","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7614-9545","authenticated-orcid":false,"given":"Katherine","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9206-8244","authenticated-orcid":false,"given":"Pat","family":"Kohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4911-8192","authenticated-orcid":false,"given":"Alvin G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-0856","authenticated-orcid":false,"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3263-8917","authenticated-orcid":false,"given":"Joel S.","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1680-1465","authenticated-orcid":false,"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-6721","authenticated-orcid":false,"given":"Natalia","family":"Vilor-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-5403","authenticated-orcid":false,"given":"Pablo","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Marqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Victoria","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-3009","authenticated-orcid":false,"given":"Merc\u00e8","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0552","authenticated-orcid":false,"given":"Tammie","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-0831","authenticated-orcid":false,"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8021-4070","authenticated-orcid":false,"given":"Yun Ju","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"872_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer\u2019s Association.","year":"2024","unstructured":"Alzheimer\u2019s Association. 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 20, 3708\u20133821 (2024).","journal-title":"Alzheimers Dement."},{"key":"872_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E. C. B. et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 26, 769\u2013780 (2020).","journal-title":"Nat. Med."},{"key":"872_CR3","doi-asserted-by":"publisher","first-page":"22406","DOI":"10.1038\/s41598-023-49440-3","volume":"13","author":"MB de Geus","year":"2023","unstructured":"de Geus, M. B. et al. Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer\u2019s disease in a large clinical sample. Sci. Rep. 13, 22406 (2023).","journal-title":"Sci. Rep."},{"key":"872_CR4","doi-asserted-by":"publisher","first-page":"106286","DOI":"10.1016\/j.nbd.2023.106286","volume":"186","author":"L Higginbotham","year":"2023","unstructured":"Higginbotham, L. et al. Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment. Neurobiol. Dis. 186, 106286 (2023).","journal-title":"Neurobiol. Dis."},{"key":"872_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","volume":"14","author":"EB Dammer","year":"2022","unstructured":"Dammer, E. B. et al. Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 14, 174 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"eabq5923","DOI":"10.1126\/scitranslmed.abq5923","volume":"15","author":"YJ Sung","year":"2023","unstructured":"Sung, Y. J. et al. Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease. Sci. Transl. Med. 15, eabq5923 (2023).","journal-title":"Sci. Transl. Med."},{"key":"872_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.02.014","author":"M Ali","year":"2025","unstructured":"Ali, M. et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2025.02.014 (2025).","journal-title":"Neuron"},{"key":"872_CR8","doi-asserted-by":"publisher","first-page":"eadn3504","DOI":"10.1126\/scitranslmed.adn3504","volume":"16","author":"EB Dammer","year":"2024","unstructured":"Dammer, E. B. et al. Proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid reveals alterations associated with APOE \u03b54 and atomoxetine treatment. Sci. Transl. Med. 16, eadn3504 (2024).","journal-title":"Sci. Transl. Med."},{"key":"872_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","volume":"7","author":"L Ping","year":"2020","unstructured":"Ping, L. et al. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer\u2019s disease. Sci. Data 7, 315 (2020).","journal-title":"Sci. Data"},{"key":"872_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41514-023-00112-6","volume":"9","author":"JA Roberts","year":"2023","unstructured":"Roberts, J. A. et al. Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer\u2019s disease brain proteomic signature. NPJ Aging 9, 18 (2023).","journal-title":"NPJ Aging"},{"key":"872_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","volume":"93","author":"L Chouliaras","year":"2022","unstructured":"Chouliaras, L. et al. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 93, 651\u2013658 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"872_CR12","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1002\/alz.12961","volume":"19","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer\u2019s disease. Alzheimers Dement. 19, 3350\u20133364 (2023).","journal-title":"Alzheimers Dement."},{"key":"872_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s43587-024-00693-1","volume":"4","author":"EA Frick","year":"2024","unstructured":"Frick, E. A. et al. Serum proteomics reveal APOE-\u03b54-dependent and APOE-\u03b54-independent protein signatures in Alzheimer\u2019s disease. Nat. Aging 4, 1446\u20131464 (2024).","journal-title":"Nat. Aging"},{"key":"872_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473\u2013489 (2021).","journal-title":"Nat. Aging"},{"key":"872_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","volume":"4","author":"Y Guo","year":"2024","unstructured":"Guo, Y. et al. Plasma proteomic profiles predict future dementia in healthy adults. Nat. Aging 4, 247\u2013260 (2024).","journal-title":"Nat. Aging"},{"key":"872_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","volume":"10","author":"M Sattlecker","year":"2014","unstructured":"Sattlecker, M. et al. Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement. 10, 724\u2013734 (2014).","journal-title":"Alzheimers Dement."},{"key":"872_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12369","volume":"18","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer\u2019s disease screening and staging. Alzheimers Dement. 18, 88\u2013102 (2022).","journal-title":"Alzheimers Dement."},{"key":"872_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan, C. D. et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol. Commun. 7, 169 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"872_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14413","author":"L Ibanez","year":"2025","unstructured":"Ibanez, L. et al. Benchmarking of a multi-biomarker low-volume panel for Alzheimer\u2019s disease and related dementia research. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.14413 (2025).","journal-title":"Alzheimers Dement."},{"key":"872_CR20","doi-asserted-by":"publisher","unstructured":"Vegting, Y. et al. Infiltrative classical monocyte-derived and SPP1 lipid-associated macrophages mediate inflammation and fibrosis in ANCA-associated glomerulonephritis. Nephrol. Dial. Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfae292 (2024).","DOI":"10.1093\/ndt\/gfae292"},{"key":"872_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/alz.13474","volume":"20","author":"KdP Lopes","year":"2024","unstructured":"Lopes, K. d. P. et al. Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults. Alzheimers Dement. 20, 525\u2013537 (2024).","journal-title":"Alzheimers Dement."},{"key":"872_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s12276-024-01176-4","volume":"56","author":"BJ Choi","year":"2024","unstructured":"Choi, B. J., Park, M. H., Jin, H. K. & Bae, J.-S. Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer\u2019s disease. Exp. Mol. Med. 56, 301\u2013310 (2024).","journal-title":"Exp. Mol. Med."},{"key":"872_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0006-3223(94)00123-K","volume":"37","author":"WF Gattaz","year":"1995","unstructured":"Gattaz, W. F., Maras, A., Cairns, N. J., Levy, R. & F\u00f6rstl, H. Decreased phospholipase A2 activity in Alzheimer brains. Biol. Psychiatry 37, 13\u201317 (1995).","journal-title":"Biol. Psychiatry"},{"key":"872_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.brainresbull.2020.05.005","volume":"163","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Regulation of SPARC family proteins in disorders of the central nervous system. Brain Res. Bull. 163, 178\u2013189 (2020).","journal-title":"Brain Res. Bull."},{"key":"872_CR25","doi-asserted-by":"publisher","first-page":"e1004574","DOI":"10.1371\/journal.pcbi.1004574","volume":"11","author":"WM Song","year":"2015","unstructured":"Song, W. M. & Zhang, B. Multiscale embedded gene co-expression network analysis. PLoS Comput. Biol. 11, e1004574 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"872_CR26","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1016\/j.cell.2024.08.049","volume":"187","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease. Cell 187, 6309\u20136326.e15 (2024).","journal-title":"Cell"},{"key":"872_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"NR Barth\u00e9lemy","year":"2024","unstructured":"Barth\u00e9lemy, N. R. et al. Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests. Nat. Med. 30, 1085\u20131095 (2024).","journal-title":"Nat. Med."},{"key":"872_CR28","doi-asserted-by":"publisher","unstructured":"Bateman, R. J. et al. Amyloid reduction and dementia progression in dominantly inherited Alzheimer\u2019s disease after long-term gantenerumab treatment: results from the DIAN-TU trial. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.10.29.24316289 (2024).","DOI":"10.1101\/2024.10.29.24316289"},{"key":"872_CR29","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"872_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","volume":"20","author":"JC Morris","year":"2006","unstructured":"Morris, J. C. et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis. Assoc. Disord. 20, 210\u2013216 (2006).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"872_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0000000000003770","volume":"88","author":"GS Day","year":"2017","unstructured":"Day, G. S. et al. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology 88, 1273\u20131281 (2017).","journal-title":"Neurology"},{"key":"872_CR32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"872_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"872_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41597-024-03485-9","volume":"11","author":"MV Fernandez","year":"2024","unstructured":"Fernandez, M. V. et al. Genetic and multi-omic resources for Alzheimer disease and related dementia from the Knight Alzheimer Disease Research Center. Sci. Data 11, 768 (2024).","journal-title":"Sci. Data"},{"key":"872_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS Oh","year":"2023","unstructured":"Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"872_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s40478-020-01072-8","volume":"8","author":"L Ibanez","year":"2020","unstructured":"Ibanez, L. et al. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease. Acta Neuropathol. Commun. 8, 196 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"872_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-016-0097-0","volume":"11","author":"BA Benitez","year":"2016","unstructured":"Benitez, B. A. et al. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson\u2019s disease. Mol. Neurodegener. 11, 29 (2016).","journal-title":"Mol. Neurodegener."},{"key":"872_CR38","doi-asserted-by":"publisher","first-page":"e095579","DOI":"10.1002\/alz.095579","volume":"20","author":"M Bringmann","year":"2024","unstructured":"Bringmann, M., Imam, F. & Krish, V. The Global Neurodegeneration Proteomics Consortium \u2013 biomarker and drug target discovery across 40,000 biosamples for AD, PD, ALS, FTD, and aging. Alzheimers Demen. 20, e095579 (2024).","journal-title":"Alzheimers Demen."},{"key":"872_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.trci.2016.02.003","volume":"2","author":"JL Molinuevo","year":"2016","unstructured":"Molinuevo, J. L. et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer\u2019s disease. Alzheimers Dement. (N. Y.) 2, 82\u201392 (2016).","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"872_CR40","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/alz.13537","volume":"20","author":"N Vilor-Tejedor","year":"2024","unstructured":"Vilor-Tejedor, N. et al. Genetic characterization of the ALFA study: uncovering genetic profiles in the Alzheimer\u2019s continuum. Alzheimers Dement. 20, 1703\u20131715 (2024).","journal-title":"Alzheimers Dement."},{"key":"872_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/alz.12131","volume":"16","author":"M Mil\u00e0-Alom\u00e0","year":"2020","unstructured":"Mil\u00e0-Alom\u00e0, M. et al. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimers Dement. 16, 1358\u20131371 (2020).","journal-title":"Alzheimers Dement."},{"key":"872_CR42","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/archneur.60.10.1394","volume":"60","author":"OL Lopez","year":"2003","unstructured":"Lopez, O. L. et al. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch. Neurol. 60, 1394\u20131399 (2003).","journal-title":"Arch. Neurol."},{"key":"872_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 10, 844\u2013852 (2014).","journal-title":"Alzheimers Dement."},{"key":"872_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: a concept in evolution. J. Intern. Med. 275, 214\u2013228 (2014).","journal-title":"J. Intern. Med."},{"key":"872_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303\u2013308 (1999).","journal-title":"Arch. Neurol."},{"key":"872_CR46","doi-asserted-by":"publisher","first-page":"e76436","DOI":"10.1371\/journal.pone.0076436","volume":"8","author":"M Alegret","year":"2013","unstructured":"Alegret, M. et al. Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old. PLoS ONE 8, e76436 (2013).","journal-title":"PLoS ONE"},{"key":"872_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13803395.2011.630652","volume":"34","author":"M Alegret","year":"2012","unstructured":"Alegret, M. et al. Normative data of a brief neuropsychological battery for Spanish individuals older than 49. J. Clin. Exp. Neuropsychol. 34, 209\u2013219 (2012).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"872_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA\u2013AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"872_CR49","first-page":"100","volume":"4","author":"O Rodriguez-Gomez","year":"2017","unstructured":"Rodriguez-Gomez, O. et al. FACEHBI: a prospective study of risk factors, biomarkers and cognition in a cohort of individuals with subjective cognitive decline. Study rationale and research protocols. J. Prev. Alzheimers Dis. 4, 100\u2013108 (2017).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"872_CR50","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jalz.2019.06.4950","volume":"15","author":"S Moreno-Grau","year":"2019","unstructured":"Moreno-Grau, S. et al. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer\u2019s disease and three causality networks: the GR@ACE project. Alzheimers Dement. 15, 1333\u20131347 (2019).","journal-title":"Alzheimers Dement."},{"key":"872_CR51","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.3390\/ijms23136891","volume":"23","author":"A Orellana","year":"2022","unstructured":"Orellana, A. et al. Establishing in-house cutoffs of CSF Alzheimer\u2019s disease biomarkers for the AT(N) stratification of the Alzheimer Center Barcelona cohort. Int. J. Mol. Sci. 23, 6891 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"872_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","volume":"147","author":"J Rutledge","year":"2024","unstructured":"Rutledge, J. et al. Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease. Acta Neuropathol. 147, 52 (2024).","journal-title":"Acta Neuropathol."},{"key":"872_CR53","doi-asserted-by":"publisher","first-page":"e12921","DOI":"10.15252\/emmm.202012921","volume":"12","author":"M Su\u00e1rez-Calvet","year":"2020","unstructured":"Su\u00e1rez-Calvet, M. et al. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in A\u03b2 pathology are detected. EMBO Mol. Med. 12, e12921 (2020).","journal-title":"EMBO Mol. Med."},{"key":"872_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","volume":"8","author":"H Vanderstichele","year":"2012","unstructured":"Vanderstichele, H. et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement. 8, 65\u201373 (2012).","journal-title":"Alzheimers Dement."},{"key":"872_CR55","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson, O. et al. The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 18, 2669\u20132686 (2022).","journal-title":"Alzheimers Dement."},{"key":"872_CR56","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"872_CR57","doi-asserted-by":"publisher","first-page":"e14413","DOI":"10.1002\/alz.14413","volume":"21","author":"L Ibanez","year":"2025","unstructured":"Ibanez, L. et al. Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research. Alzheimers Dement. 21, e14413 (2025).","journal-title":"Alzheimers Dement."},{"key":"872_CR58","doi-asserted-by":"publisher","first-page":"106373","DOI":"10.1016\/j.nbd.2023.106373","volume":"190","author":"J Timsina","year":"2024","unstructured":"Timsina, J. et al. Harmonization of CSF and imaging biomarkers in Alzheimer\u2019s disease: need and practical applications for genetics studies and preclinical classification. Neurobiol. Dis. 190, 106373 (2024).","journal-title":"Neurobiol. Dis."},{"key":"872_CR59","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.1038\/s41598-021-86465-y","volume":"11","author":"S Yoon","year":"2021","unstructured":"Yoon, S., Baik, B., Park, T. & Nam, D. Powerful p-value combination methods to detect incomplete association. Sci. Rep. 11, 6980 (2021).","journal-title":"Sci. Rep."},{"key":"872_CR60","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2, 100141 (2021).","journal-title":"Innovation (Camb.)"},{"key":"872_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"872_CR62","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1002\/alz.12969","volume":"19","author":"E Wang","year":"2023","unstructured":"Wang, E. et al. Genome-wide methylomic regulation of multiscale gene networks in Alzheimer\u2019s disease. Alzheimers Dement. 19, 3472\u20133495 (2023).","journal-title":"Alzheimers Dement."},{"key":"872_CR63","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1038\/s41598-018-27293-5","volume":"8","author":"AT McKenzie","year":"2018","unstructured":"McKenzie, A. T. et al. Brain cell type specific gene expression and co-expression network architectures. Sci. Rep. 8, 8868 (2018).","journal-title":"Sci. Rep."},{"key":"872_CR64","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","volume":"8","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease. Genome Med. 8, 104 (2016).","journal-title":"Genome Med."},{"key":"872_CR65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-018-0642-x","volume":"6","author":"Y Kajiwara","year":"2018","unstructured":"Kajiwara, Y. et al. GJA1 (connexin43) is a key regulator of Alzheimer\u2019s disease pathogenesis. Acta Neuropathol. Commun. 6, 144 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"872_CR66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajhg.2019.01.002","volume":"104","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. ACAT: a fast and powerful p value combination method for rare-variant analysis in sequencing studies. Am. J. Hum. Genet. 104, 410\u2013421 (2019).","journal-title":"Am. J. Hum. Genet."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00872-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:03:05Z","timestamp":1750237385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-025-00872-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1038\/s43587-025-00872-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5167552\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C. has received research support from GSK and Eisai. C.C. is a member of the scientific advisory board of Circular Genomics and owns stocks. C.C. is a member of the scientific advisory board of ADmit. There is an invention disclosure for the prediction models, including protein IDs, alternative proteins and weights, cutoff and algorithms. C.C. has served on the scientific advisory boards of GSK and Novo Nordisk. D.M.H. is a cofounder with equity in C2N Diagnostics. D.M.H. is on the scientific advisory boards of Genentech, Denali, C2N Diagnostics and Cajal Neurosciences. D.M.H. consults for Asteroid, Acta Pharmaceuticals, Alnylam, Pfizer and Switch. T.W.-C. and H.S.-H.O. are cofounders and scientific advisors of Teal Omics and have received equity stakes. T.W.-C. is a cofounder and scientific advisor of Alkahest and Qinotto and has received equity stakes in these companies. S.E.S. has served on scientific advisory boards on biomarker testing and clinical care pathways for Eisai and Novo Nordisk and has received speaking fees for presentations on biomarker testing from Eisai, Eli Lilly and Novo Nordisk. M.S.-C. has received consultancy\/speaker fees (paid to the institution) from Almirall, Eli Lilly, Novo Nordisk and Roche Diagnostics in the past 36 months. M.S.-C. has received consultancy fees or served on the advisory boards (paid to the institution) of Eli Lilly, Grifols, Novo Nordisk and Roche Diagnostics. M.S.-C. was granted a project and is a site investigator of a clinical trial (funding granted to the institution) by Roche Diagnostics. M.S.-C. did not receive any personal compensation from these organizations or any other for-profit organization. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}